Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$23.68 +0.73 (+3.18%)
(As of 12/20/2024 ET)

About ARK Genomic Revolution ETF (BATS:ARKG)

Key Stats

Today's Range
$22.72
$24.04
50-Day Range
$22.66
$27.10
52-Week Range
N/A
Volume
7.04 million shs
Average Volume
N/A
Market Capitalization
$1.34 billion
Assets Under Management
$1.05 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.55%0.57%0.52%
Other Expenses0.00%0.57%0.49%0.47%0.53%
Total Expense0.75%0.72%0.71%0.69%0.71%
Fee Waiver0.00%-0.74%-0.51%-0.36%-0.56%
Net Expense0.75%0.60%0.61%0.65%0.59%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

ARKG ETF News Headlines

Unusually active option classes on open November 25th
Unusually active option classes on open November 14th
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $32.81 at the start of the year. Since then, ARKG shares have decreased by 27.8% and is now trading at $23.68.
View the best growth stocks for 2024 here
.

Top institutional investors of ARK Genomic Revolution ETF include Main Management ETF Advisors LLC (4.30%), Main Management LLC (1.16%), Jane Street Group LLC and Barclays PLC (0.50%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), ARK Innovation ETF (ARKK), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
38

Fund Statistics

Assets Under Management
$1.05 billion
Average Daily Volume
$2.67 million
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
The Bank of NewYork Mellon Corporation
Advisor
ARK Investment Management LLC
Custodian
The Bank of NewYork Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of NewYork Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
31,117
Put Options
20,280
Call Options
10,837

Miscellaneous

Beta
1.99
Creation Unit
50,000
Creation Fee
$500.00
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners